# Medtronic vs Sanofi: valuation, size and margins compared

URL: https://funkfolio.com/compare/mdt-vs-sny

> Medtronic ($130.9B, P/E 25.3) and Sanofi ($114.1B, P/E 24.0) compared: size, valuation, margins, debt, cash and price change.

---

## Medtronic vs Sanofi

Medtronic (MDT), health care, and Sanofi (SNY), health care, side by side on market value, valuation, margins, balance sheet and price change. Higher and lower are marked; neither is called better.

Medtronic is worth $130.9B on the stock market and Sanofi $114.1B: Medtronic is valued at 15% more. Medtronic trades at 25.3 times earnings and Sanofi at 24.0; operating margins in their latest fiscal years were 17.8% and 14.5%. Over the past year Medtronic's share price has moved +2.06% and Sanofi's -4.48%.

### Key facts

- **Medtronic market value:** $130.9B
- **Sanofi market value:** $114.1B
- **Medtronic P/E:** 25.3
- **Sanofi P/E:** 24.0
- **Medtronic revenue:** $36.4B FY to 2026-04-24
- **Sanofi revenue:** $48.4B FY to 2025-12-31
- **Superinvestors holding both:** 2

Market values as of 18 Nov 2026, 05:03 UTC.

Medtronic vs Sanofi: every measure side by side

| Measure | Medtronic | Sanofi |
| --- | --- | --- |
| Sector | Health Care | Health Care |
| Country | Ireland | France |
| Fiscal year ends | 2026-04-24 | 2025-12-31 |
| Size |  |  |
| Market cap | $130.9B higher | $114.1B lower |
| Revenue | $36.4B lower | $48.4B higher |
| Earnings | $4.8B lower | $8.7B higher |
| Employees | 95,000 higher | 74,846 lower |
| Total assets | $93B lower | $140.7B higher |
| Valuation |  |  |
| P/E | 25.3 higher | 24.0 lower |
| P/S | 3.6 higher | 2.4 lower |
| P/B | — | — |
| Dividend yield | — | — |
| Profitability |  |  |
| Operating margin | 17.8% higher | 14.5% lower |
| Balance sheet |  |  |
| Net assets | $49.5B lower | $79.2B higher |
| Total liabilities | $43B lower | $61.1B higher |
| Total debt | $28B higher | $20.8B lower |
| Cash on hand | $1.9B lower | $8.5B higher |
| Price change |  |  |
| Today | -0.54% higher | -1.78% lower |
| 1 year | +2.06% higher | -4.48% lower |

Market value, P/E, P/B, dividend yield and price changes are from live quotes (Yahoo Finance; prices may be delayed 15 minutes or more). Revenue, earnings, operating margin and the balance-sheet figures are from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day. P/S sets today's market value against the latest fiscal year's revenue. “Higher” and “lower” compare the two numbers only; a higher P/E or more debt is not better. Dividend yield and P/B are shown only for companies based in the US. A dash means no figure is on file.

### Share price over one year

Each company's share price rebased to 100 on Nov 17, 2025, so the two lines start together. Price only: dividends are not included. Last: Medtronic 106.3, Sanofi 91.8.

- Medtronic (MDT)
- Sanofi (SNY)

Medtronic and Sanofi share prices over one year, rebased to 100: Medtronic ends at 106.3, Sanofi at 91.8.

**The chart as a table**

Month-end share prices rebased to 100

| Month end | MDT | SNY |
| --- | --- | --- |
| Nov 28, 2025 | 109.4 | 96.3 |
| Dec 31, 2025 | 99.8 | 93.6 |
| Jan 30, 2026 | 106.9 | 90.8 |
| Feb 27, 2026 | 101.4 | 94.0 |
| Mar 31, 2026 | 90.0 | 93.0 |
| Apr 30, 2026 | 84.1 | 90.0 |
| May 29, 2026 | 76.7 | 84.3 |
| Jun 30, 2026 | 81.3 | 82.4 |
| Jul 31, 2026 | 88.7 | 83.2 |
| Aug 31, 2026 | 94.2 | 85.7 |
| Sep 30, 2026 | 89.6 | 79.6 |
| Oct 30, 2026 | 100.3 | 85.6 |
| Nov 17, 2026 | 106.3 | 91.8 |

### Which superinvestors hold them

From each tracked investor's latest 13F filing. A 13F lists long positions in US-listed shares at a quarter end, filed up to 45 days later.

#### Both (2)

- [Richard Pzena](https://funkfolio.com/gurus/richard-pzena) 0.8% / &lt;0.1%
- [Dodge & Cox team](https://funkfolio.com/gurus/dodge-and-cox) 0.3% / 0.3%

#### Medtronic only (8)

- [Matthew McLennan](https://funkfolio.com/gurus/first-eagle) 1.9%
- [Diamond Hill team](https://funkfolio.com/gurus/diamond-hill) 1.4%
- [Howard Gleicher](https://funkfolio.com/gurus/howard-gleicher) 1.2%
- [Mark Boyar](https://funkfolio.com/gurus/mark-boyar) 0.4%
- [Mairs & Power team](https://funkfolio.com/gurus/mairs-and-power) 0.3%
- [Ken Griffin](https://funkfolio.com/gurus/ken-griffin) 0.2%
- [David Shaw (founder)](https://funkfolio.com/gurus/david-shaw) 0.2%
- [Ray Dalio (founder)](https://funkfolio.com/gurus/bridgewater) 0.2%

#### Sanofi only (5)

- [Charles Brandes (founder)](https://funkfolio.com/gurus/charles-brandes) 1.2%
- [Louis Bacon](https://funkfolio.com/gurus/louis-bacon) 0.5%
- [Sarah Ketterer](https://funkfolio.com/gurus/sarah-ketterer) 0.4%
- [Ken Fisher](https://funkfolio.com/gurus/ken-fisher) 0.1%
- [Lee Ainslie](https://funkfolio.com/gurus/lee-ainslie) &lt;0.1%

Percentages are each holding's share of that investor's reported portfolio (under "Both": Medtronic / Sanofi). [Who owns MDT](https://funkfolio.com/stock/MDT/superinvestors) · [Who owns SNY](https://funkfolio.com/stock/SNY/superinvestors)

### More on Medtronic

- [Medtronic (MDT) stock page](https://funkfolio.com/stock/MDT)
- [Medtronic market cap](https://funkfolio.com/stock/MDT/market-cap)
- [Medtronic revenue](https://funkfolio.com/stock/MDT/revenue)
- [Medtronic P/E ratio](https://funkfolio.com/stock/MDT/pe-ratio)
- [Medtronic operating margin](https://funkfolio.com/stock/MDT/operating-margin)
- [Medtronic total debt](https://funkfolio.com/stock/MDT/total-debt)
- [Largest health care companies](https://funkfolio.com/companies/sector/health-care)

### More on Sanofi

- [Sanofi (SNY) stock page](https://funkfolio.com/stock/SNY)
- [Sanofi market cap](https://funkfolio.com/stock/SNY/market-cap)
- [Sanofi revenue](https://funkfolio.com/stock/SNY/revenue)
- [Sanofi P/E ratio](https://funkfolio.com/stock/SNY/pe-ratio)
- [Sanofi operating margin](https://funkfolio.com/stock/SNY/operating-margin)
- [Sanofi total debt](https://funkfolio.com/stock/SNY/total-debt)
- [Largest health care companies](https://funkfolio.com/companies/sector/health-care)

### Further comparisons

#### Medtronic against its closest peers

- [Medtronic vs Bristol-Myers Squibb](https://funkfolio.com/compare/bmy-vs-mdt)
- [Medtronic vs Vertex Pharmaceuticals](https://funkfolio.com/compare/mdt-vs-vrtx)
- [Medtronic vs Stryker](https://funkfolio.com/compare/mdt-vs-syk)
- [Medtronic vs McKesson](https://funkfolio.com/compare/mck-vs-mdt)

#### Sanofi against its closest peers

- [Sanofi vs Moderna](https://funkfolio.com/compare/mrna-vs-sny)
- [Sanofi vs McKesson](https://funkfolio.com/compare/mck-vs-sny)
- [Sanofi vs CVS Health](https://funkfolio.com/compare/cvs-vs-sny)
- [Sanofi vs Stryker](https://funkfolio.com/compare/sny-vs-syk)

### Learn

- [What market capitalization is and is not](https://funkfolio.com/learn/markets/market-capitalization)
- [P/E ratio explained](https://funkfolio.com/learn/stocks/pe-ratio)
- [Market cap vs enterprise value](https://funkfolio.com/learn/markets/market-cap-vs-enterprise-value)

### Questions and answers

**Which is bigger, Medtronic or Sanofi?**

By market value, Medtronic is the larger: $130.9B against $114.1B for Sanofi. By revenue in its latest fiscal year, Sanofi is the larger: $48.4B against $36.4B for Medtronic.

**Which has the higher P/E ratio?**

Medtronic: 25.3, against 24.0 for Sanofi. A higher P/E means the market pays more for each dollar of the last twelve months' earnings; on its own it does not say which is the better value.

**Which has the higher operating margin?**

Medtronic: 17.8%, against 14.5% for Sanofi. Operating margin is operating income as a share of revenue in the latest fiscal year.

**Which has more debt?**

Medtronic: $28B, against $20.8B for Sanofi. Total debt is borrowings at the end of the latest fiscal year, as each company reported it; it is not set against cash here.

**Which superinvestors own both Medtronic and Sanofi?**

In their latest 13F filings, Richard Pzena and Dodge & Cox team hold both.

### Cite this page

Funkfolio, “Medtronic vs Sanofi”, data as of 18 November 2026. https://funkfolio.com/compare/mdt-vs-sny

Underlying data: Yahoo Finance quotes; SEC annual reports collected 2026-11-12; 13F filings.
